Table 4.
Linear regression analyses of association betweenGCH1-SNP combination and hormonal contraceptives use among patients with current treatment (n = 36)
| |
Coital VAS pain score |
||
|---|---|---|---|
| df | F | p | |
|
GCH1-SNP combination |
1 |
4.71 |
.037* |
|
Hormonal contraceptives use |
1 |
.11 |
.726 |
|
GCH1- SNP combination *hormonal contraceptives use |
1 |
4.69 |
.038* |
| |
Adj R2 = 0.084 |
||
| |
PPT arm |
||
| |
df |
F |
p |
|
GCH1- SNP combination |
1 |
4.64 |
.039* |
|
Hormonal contraceptives use |
1 |
1.49 |
.233 |
|
GCH1- SNP combination *hormonal contraceptives use |
1 |
4.632 |
.039* |
| |
Adj R2 = 0.054 |
||
| |
PPT leg |
||
| |
df |
F |
p |
|
GCH1- SNP combination |
1 |
3.92 |
.056 |
|
Hormonal contraceptives use |
1 |
2.21 |
.147 |
|
GCH1- SNP combination *hormonal contraceptives use |
1 |
3.90 |
.057 |
| Adj R2 = 0.058 | |||
SNP = single nucleotide polymorphism, VAS = visual analogue scale, PPT = pressure pain threshold.